VZL 2006, 75(3):92-100

Selected Aspects Influencing the Quality of Life in Patients with Multiple Myeloma and Malignant Lymphoma after the Hematopoietic Stem cell Transplantation

Ladislav Slováček1,2, Birgita Slováčková3, Ladislav Jebavý1,2
1 Univerzita obrany, katedra válečného vnitřního lékařství Fakulty vojenského zdravotnictví, Hradec Králové
2 Oddělení klinické hematologie II. interní kliniky, Fakultní nemocnice a Lékařská fakulta UK, Hradec Králové
3 Psychiatrická klinika, Fakultní nemocnice a Lékařská fakulta UK, Hradec Králové

Studie analyzuje vliv vybraných aspektů na globální kvalitu života u nemocných s mnohočetným myelomem a maligním lymfomem po transplantaci krvetvorných buněk na Oddělení klinické hematologie II. interní kliniky Fakultní nemocnice a Lékařské fakulty Univerzity Karlovy v Hradci Králové v letech 2001-2003. Celkový počet respondentů byl 80, návratnost dotazníků byla 70%, tj. od 56 respondentů - 32 s mnohočetným myelomem, věkový medián byl 60 let a 24 s maligním lymfomem, věkový medián byl 46,5 roku. K otestování respondentů byla použita česká verze mezinárodního generického dotazníku European Quality of Life Questionnaire - Version EQ-5D. Vliv vybraných aspektů na globální kvalitu života (typ transplantace krvetvorných buněk - autologní, alogenní, věk, pohlaví, vzdělání, rodinný stav, religiozita, nikotinismus, typ onemocnění a časový odstup od provedení transplantace krvetvorných buněk byl proveden analýzou rozptylu. Z uvedených aspektů byla prokázána statisticky významná závislost EQ-5D indexu a EQ-5D VAS na věku a typu onemocnění u obou kohort nemocných (v obou případech p < 0,01) a na nikotinismu u nemocných s mnohočetným myelomem (v obou případech p < 0,05). Vliv ostatních aspektů se jako statisticky významný neprokázal. Globální kvalita života nemocných s mnohočetným myelomem po transplantaci krvetvorných buněk je nižší v porovnání s nemocnými s maligním lymfomem po transplantaci krvetvorných buněk na našem oddělení, o čemž vypovídají průměrné hodnoty EQ-5D indexu (68,9 % u nemocných s mnohočetným myelomem a 82,7 % u nemocných s maligním lymfomem) a průměrné hodnoty EQ-5D VAS (66,6 % u nemocných s mnohočetným myelomem a 76,7 % u nemocných s maligním lymfomem).

Keywords: Kvalita života; Mnohočetný myelom; Maligní lymfom; Transplantace krvetvorných buněk; Dotazníky kvality života

Aim: The study analyses the influence of selected aspects on the global quality of life in patients with multiple myeloma and malignant lymphoma after the hematopoietic stem cell transplantation at the Department of Clinical Hematology of the Second Internal Clinic of the University Hospital and Medical Faculty of Charles University in Hradec Králové from 2001 to 2003.

Patients and Methods: The total number of respondents after the transplantation was 80 and the return rate of questionnaire was 70% (56 respondents - 32 with multiple myeloma - average age was 60 years and 24 with malignant lymphoma - average age was 46,5 years). The Czech version of the international generic European Quality of Life Questionnaire - Version EQ-5D was used. The influence of monitored aspects (the type of transplantation - autologous, allogenous, age, sex, education, marital status, religion, nicotinism, the type of disease and the time-gap from the transplantation) on the global quality of life in patients was performed by means of analysis of variance.

Results: The above-mentioned aspects proved statistically significant dependence of EQ-5D index and EQ-5D VAS on the age (in both cases p < 0,01) and on the type of disease (in both cases p < 0,01) in both groups of patients and on nicotinism in patients with multiple myeloma (in both cases p < 0,05). EQ-5D index and EQ-5D VAS significantly decrease with increasing age and type of disease in both groups and nicotinism in patients with multiple myeloma. The influence of other factors on EQ-5D index and EQ-5D VAS was not proven as statistically significant.

Conclusion: The global quality of life in patients with multiple myeloma after the hematopoietic stem cell transplantation is lower than in patients with malignant lymphoma after the transplantation performed at our department, what show us the average values of EQ-5D index (68,9 % in patients with multiple myeloma and 82,7 % in patients with malignant lymphoma) and the average values of EQ-5D VAS (66,6 % in patients with multiple myeloma and 76,7 % in patients with malignant lymphoma).

Keywords: Quality of life; Multiple myeloma; Malignant lymphoma; Hematopoietic stem cell transplantation; Quality of life questionnaire

Received: November 25, 2005; Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slováček, L., Slováčková, B., & Jebavý, L. (2006). Selected Aspects Influencing the Quality of Life in Patients with Multiple Myeloma and Malignant Lymphoma after the Hematopoietic Stem cell Transplantation. Vojenské Zdravotnické Listy75(3-4), 92-100
Download citation

References

  1. ANDĚL, M., aj. Vnitřní lékařství - díl IIIb - hematologie. Praha, Galén, 2001.
  2. BAKER, F. - ZABORA, J. - POLLAND, A., et al. Reintegration after bone marrow transplantation. Cancer Pract., 1999, vol. 7, no. 4, p. 190-197. Go to original source... Go to PubMed...
  3. CARLSON, LE. - Mac RAE, JH. Quality of life issues following autologous bone marrow transplantation. Expert. Rev. Pharmacoeconomics Outcomes Res., 2002, vol. 2, no. 2, p. 129-146. Go to original source... Go to PubMed...
  4. DURAES, MIC. Influencia da fonte de célula (progenitora periférica ou medula óssea) na qualidada de vida de pacientes onco-hematológicos submetidos ao transplante alogenico de medula óssea. Rev. Bras. Haematol. Hemoter., 2002, vol. 24, no. 1, p. 63-64. Go to original source...
  5. HEINONEN, H. - VOLIN, L. - UUTELA, A., et al. Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant., 2001, vol. 28, no. 5, p. 503-509. Go to original source... Go to PubMed...
  6. HEINONEN, H. - VOLIN, L. - UUTELA, A., et al. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann. Hematol., 2001, vol. 80, no. 3, p. 137-143. Go to original source... Go to PubMed...
  7. KOPP, M. - SCHWEIGKOFLER, H. - HOLZNER, B., et al. B. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplantat recipients: a comparison. Eur. J. Haematol., 2000, vol. 65, no. 2, p. 97-103. Go to original source... Go to PubMed...
  8. SO, WK. - DODGSON, J. - TAI, JW. Fatigue and quality of life among Chinese patients with hematologic malignancy and bone marrow transplantation. Cancer Nurs, 2003, vol. 26, no. 3, p. 211-219. Go to original source... Go to PubMed...
  9. WANG, WQ. - Lin, GW. Study on quality of life in long-term survivors with acute leukemia in Shanghay. J. Cancer, 2003, vol. 24, no. 11, p. 1049-1051.
  10. ZITTOUN, R. - ACHARD, S. - RUSZNIEWSKI, M. Assessement of quality of life during intensive chemotherapy bone marrow transplantation. Psychooncology, 1999, vol. 8, no. 1, p. 64-73. Go to original source...
  11. BOYLE, D. - BLODGETT, L. - GNESDILOFF, S., et al. Caregiver quality of life after autologous bone marrow transplantation. Cancer Nurs, 2000, vol. 23, no. 3, p. 193-203. Go to original source... Go to PubMed...
  12. BROERS, S. - KAPTEIN, AA. - Le CESSIE, S., et al. Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. J. Psychosom. Res., 2000, vol. 48, no. 1, p. 11-21. Go to original source... Go to PubMed...
  13. BUSSCHBACH, JJ. - McDONNELL, J. - ESSINK, ML., et al. Etimating parametric relationships between health desciption and health valuation with an application to the EuroQol EQ-5D. J. Health Econ., 1999, vol. 18, no. 5, p. 551-571. Go to original source... Go to PubMed...
  14. ANDRYKOWSKI, MA. - GREINER, CB. - ALTMAIER, EM., et al. Quality of life following bone marrow transplantation: finding from a multicentre study. J. Cancer, 1995, vol. 71, no. 6, p. 1322-1329. Go to original source... Go to PubMed...
  15. BADIA, X. - HERDMAN, M. - SCHIAFFINO, A. Determining correspondence between scores on the EQ-5D "thermometer" and a 5-point categorical rating scale. Med. Care, 1999, vol. 37, no. 7, p. 671-677. Go to original source... Go to PubMed...
  16. The EUROQoL GROUP. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy, 1990, vol. 16, no. 3, p. 199-208. Go to original source... Go to PubMed...
  17. DE SOUZA, CA. - DURAES, MI. - VIGORITO, AC. et al. Quality of life in patients randomized to receive a bone marrow or a peripheral blood transplantation. Haematologica, 2002, vol. 87, no. 12, p. 1281-1285. Go to PubMed...
  18. CHIODI, S. - SPINELLI, S. - RAVERA, C., et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br. J. Haematol., 2000, vol. 10, no. 3, p. 614-619. Go to original source... Go to PubMed...
  19. WONG, R., et al. Reduced-intensity conditioning for unrelated donor hematopoetic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. Blood, 2003, vol. 102, no. 8, p. 3052-3059. Go to original source... Go to PubMed...
  20. HAXES, S. - DAVIES, PS. - PARKER, T et al. Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program. Bone Marrow Transplant., 2004, vol. 8, no. 6, p. 156-172.
  21. SALEH, US. - BROCKOPP, DY. Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplantation survivors tool. Oncol. Nurs Forum, 2001, vol. 28, no. 9, p. 1457-1464. Go to PubMed...
  22. CHANG, G., et al. Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics, 2004, vol. 45, no. 5, p. 378-385. Go to original source... Go to PubMed...
  23. REDAELLI, A., et al. Short and long term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat. Rev., 2004, vol. 30, no. 1, p. 103-117. Go to original source... Go to PubMed...
  24. KISS, TL. - ABDOLELL, M. - JAMAL, N., et al. Long-term medical outcomes and quality of life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J. Clin. Oncol., 2002, vol. 20, no. 9, p. 2334-2343. Go to original source... Go to PubMed...
  25. HOLZNER, B. - KEMMLER, G. - SPERNER-UNTERWEGER, B., et al. Quality of life measurement in oncology - a matter of the assessment instrument? Eur. J. Cancer, 2001, vol. 37, no. 18, p. 2349-2356. Go to original source... Go to PubMed...
  26. VAN AGTHOVEN, M., et al. Cost analysis and quality of life assessment comparing undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkins lymphoma or Hodgkins disease, a prospective randomised trial. Eur. J. Cancer, 2001, vol. 37, no. 14, p. 1781-1789. Go to original source... Go to PubMed...
  27. MOUNIER, N. - HAIOUN, C. - COLE, BF. et al. Quality of life adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Étude les Lymphomes de l'Adulte (GELA). Blood, 2000, vol. 95, no. 12, p. 3687-3692.
  28. MESANYOVÁ, M. - ŠIMEK, J. Transplantace kostní dřeně z pohledu pacienta. Prakt. Lék., 2004, roč. 84, č. 9, s. 536-540.
  29. ADAM, Z. - POUR, L. - SVOBODNÍK, A., et al. Quality of life and tolerance of maintenance therapy in patients with multiple myeloma. Vnitř. Lék., 2002, roč. 48, č. 3, s. 216-229.